Guido Oelkers Appointed President and CEO at Sobi PR Newswire STOCKHOLM, May 04, 2017 STOCKHOLM , May 04, 2017 /PRNewswire/ -- Swedish Orphan Biovitrum AB

Mr Oelkers will succeed the outgoing CEO, Geoffrey McDonough. He will relocate to Sweden, where the drugmaker is based. Mr Oelkers has held the top role at several healthcare companies, including BSN Medical GmbH and Gambro. At Sobi, he will focus on the development of drugs for rare diseases such as haemophilia, inflammation and genetic disorders.

Rare disease drug developer Swedish Orphan Biovitrum AB (Sobi) has named Guido Oelkers as the company’s new President and CEO. Oelkers, who holds a PhD in Strategic Management from the University of South Australia and a Master of Economics from South Bank University, London, joins from BSN Medical GmbH, where he held the position of CEO. Gambro is a global medical technology company focused on developing, manufacturing and supplying dialysis products and therapies for patients with acute or chronic kidney disease. The acquisition gives Baxter a comprehensive dialysis product portfolio, complements Baxter's global home dialysis offerings, and positions the company to better meet the evolving needs of the large and growing 2012-12-04 Guido Oelkers is currently the CEO of Swedish Orphan Biovitrium, a listed orphan drug company. He has extensive experience from pharmaceutical and health care companies including roles as CEO of BSN Medical, CEO of the Swedish medical device company Gambro, Guido Oelkers, 54 President & Chief Executive Officer, Swedish Orphan Biovitrum AB. Guido Oelkers is a businessperson who has been at the helm of 8 different companies. Baxter Enhances Renal Therapies Portfolio with Acquisition of Gambro.

Guido oelkers gambro

Employed since 2017. VP Corporate Communications Gambro, Financial Analyst Carnegie and Alfred Berg. Dr. Guido Oelkers joined as President and CEO of Gambro in 2011 A capital injection was provided in June 2012 to support the first phase of the new Full Potential Plan. EQT IV’s portion amounted to EUR 40 million Biography of Guido Oelkers Guido Oelkers is a businessperson who has been at the helm of 8 different companies. Guido Oelkers is President/CEO at Swedish Orphan Biovitrum AB. See Guido Oelkers's compensation, career history, education, & memberships.

ha resurser, teknologi och innovationskapacitet för att forma vår industri för framtiden”, säger Guido Oelkers, vd och koncernchef för Gambro. Det är glädjande att ha Dominique Janbon i vårt team, säger Guido Oelkers, CEO för Gambro.

16 maj 2017 Geoffrey McDonough lämnar, och Guido Oelkers tar över som och hälsovårdsföretag, bland annat från tiden som vd för Gambro och Invida.

Born 1965. President & CEO Gambro, EVP Commercial Operations Nycomed, CEO Invida, Global Head of Healthcare DKSH, Guido Oelkers kommer till Sobi från en tidigare roll som vd för BSN Medical GmbH. Han har en omfattande erfarenhet från läkemedels- och hälsovårdsföretag och har varit vd och koncernchef för svenska medicinteknikbolaget Gambro.

Guido Oelkers kommer till Sobi från en tidigare roll som vd för BSN har varit vd och koncernchef för svenska medicinteknikbolaget Gambro.

So, I hope, we were able to explain what was in – what we are able to explain at this juncture, that this deal is right on strategy 2012-12-05 · Baxter International Inc. has entered into a definitive agreement to acquire Gambro AB, a privately held dialysis product company based in Lund, Sweden, for total consideration of 26.5 billion SEK Investor and EQT to sell Gambro to Baxter. Investor (49%) and EQT IV (51%) have signed an agreement to divest Gambro to the medical technology company Baxter International Inc (“Baxter”) for a total enterprise value of SEK 26.5 bn. The value of Gambro’s equity is SEK 18.3 bn. after deducting net debt of SEK 8.2 bn. (net debt as of signing). Guido Oelkers was born in 1965 and holds a PhD in Strategic Management from the University of South Australia and a Master of Economics from South Bank University, London.

Ora che l’accordo è firmato, l'acquisizione di Gambro da parte di Baxter è condizionata unicamente all’approvazione delle competenti autorità per la concorrenza: l’operazione dovrebbe quindi essere completata entro Gambro AB är ett företag beläget i STOCKHOLM, Stockholm. Man arbetar främst med Administrativ företagsverksamhet. Gambro AB har 20 - 49 stycken anställda.
Abap itab to excel

2017-05-04 Guido Oelkers kommer till Sobi från en tidigare roll som vd för BSN Medical GmbH. Han har en omfattande erfarenhet från läkemedels- och hälsovårdsföretag och har varit vd och koncernchef för svenska medicinteknikbolaget Gambro. Guido Oelkers. Chief Executive Officer Industrial Management Swedish Orphan Biovitrum Sweden. Other appointments: Previous positions: President and CEO, Gambro, CEO, Invida, a number of executive commercial operations roles in Nycomed, DKSH Group and Aventis, member of the Board of Directors at Meda.

Guido Oelkers, Gambro chief executive, said the Swedish group and US-based Baxter shared a strong heritage in renal care and that the move would give them the muscle “to shape our industry for Startsida Karriär På nytt jobb: Gambro utser ny CFO På nytt jobb: Gambro utser ny CFO. 24 november, 2011 Mats Lövgren Karriär, Okategoriserade - Det är glädjande att ha Dominique Janbon i vårt team, säger Guido Oelkers, CEO för Gambro.
Sd vs sdhc

Healthcare company Baxter International, Inc. agreed Tuesday to acquire privately-held Swedish medical-equipment maker Gambro AB for about 26.5 billion Swedish krona or $4 billion in order to boost its dialysis product portfolio.

Unlisted. Premium. Gambro -> Baxter. BSNmedical -> SCA. 1 reply 0 retweets $SOBI Guido Oelkers, tycks ha en viss förmåga att hamna i bolag som köps.

Guido Oelkers. 850 488. 224 854. Large Cap. BALANCE. Exchange list: Large Gambro Lundia AB · Bo Magnus Lindholm. 196 602. 4 743. Unlisted. Premium.

EQT IV’s portion amounted to EUR 40 million Biography of Guido Oelkers Guido Oelkers is a businessperson who has been at the helm of 8 different companies. Guido Oelkers is President/CEO at Swedish Orphan Biovitrum AB. See Guido Oelkers's compensation, career history, education, & memberships.

seeking a comprehensive dialysis offering of proven products and therapies," Gambro CEO Guido Oelkers said. 5 Dec 2012 Based in Lund in southern Sweden, Gambro, a provider of dialysis and therapies,” Gambro CEO Guido Oelkers said in the statement. 4 Dec 2012 Gambro is a global medical technology company focused on developing said Guido Oelkers, president and chief executive officer of Gambro. 16 maj 2017 Geoffrey McDonough lämnar, och Guido Oelkers tar över som och hälsovårdsföretag, bland annat från tiden som vd för Gambro och Invida. 15. Mai 2017 München 15.05.17. Swedish Orphan Biovitrum AB (SobiTM) ernennt Guido Oelkers zum Präsident und Chief Executive Officer.